A more accurate summary is: Microdosing may help some people tolerate GLP-1 medications better Weight and metabolic effects may still occur but are likely to be slower and more modest than in full-dose trials More research is needed to define the best microdose schedule or who benefits most GLP-1 Dosing, Microdose Schedules, and Why DIY Charts Are Risky Official glp-1 dosing schedules are spelled out in each products prescribing information

resident, 18 years or older Not enrolled in Medicare, Medicaid, TRICARE, VA, or any federal or state healthcare program Not a resident of Massachusetts (state law prohibits manufacturer copay cards) What the card provides: Reduces out-of-pocket cost to as low as $0 per fill for the first 3 fills Reduces to $25 per fill for fills 4-13 Maximum program benefit of $500 per fill (if your copay is $700, you pay $200 after the card applies) Limit of 13 fills per patient over 24 months What the card does not cover: Patients whose insurance denies the Wegovy claim (no coverage to reduce) Uninsured patients paying cash Government insurance beneficiaries (federal anti-kickback statute) Deductible amounts (the card applies to copays and coinsurance, not deductibles) How to activate: Download the digital card from WegovySavings.com or request a physical card from your provider Present the card with your insurance card at the Walmart pharmacy counter The pharmacist runs insurance first, then applies the savings card to the resulting copay Activation is automatic on first use Approximately 18-22% of Wegovy prescriptions filled at retail pharmacies use the savings card based on Novo Nordisk's 2025 investor disclosures

We do not promise a specific energy level, performance gain or longevity outcome
SGLT2is was observed with significant improvements in FAI and total testosterone, outperforming GLP-1 RAs in reducing these parameters
Yes, transitioning is safe when done under medical supervision